Cellular treatment and severe primary immunodeficiency
- Early detection of relapse after paediatric hematopoietic stem cell transplantation (HSCT)
- Toxicity and immune reconstitution early post HSCT
- Late effects post HSCT
- Screening, diagnostics, and treatment in primary immunodeficiencies (PID) and bone marrow failures
Current team members
- Klaus Müller, Professor MD, PhD, DMSc
- Marianne Ifversen, Senior Consultants MD, PhD
- Tania Nicole Masmas, MD, PhD
- Hilde Hylland Uhlving, Consultant MD, PhD
- Stine Nygaard Nielsen, MD, PhD
- Katrine Kielsen, Postdoc MD, PhD
Group Leader
Group Leader: Klaus Müller, Professor MD, PhD, DMSc
Mail: klaus.mueller@regionh.dk
Profile
Publications